✦ LIBER ✦

A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients

✍ Scribed by P. Bey; P. M. Wilkinson; M. Resbeut; S. Bourdin; O. Le Floch; W. Hahne; N. Claverie

Publisher: Springer-Verlag
Year: 1996
Tongue: English
Weight: 606 KB
Volume: 4
Category: Article
ISSN: 0941-4355
DOI: 10.1007/bf01788845

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gabapentin in patients with the pruritus

Gabapentin in patients with the pruritus of cholestasis: A double-blind, randomized, placebo-controlled trial

✍ Nora V. Bergasa; Monnie McGee; Iona H. Ginsburg; Danielle Engler 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 2 views

Pruritus is defined as the second order of nociception, the first being pain; thus, there is a rationale to study gabapentin, a drug that increases the threshold to experience nociception. The aim of this double-blind, randomized, placebo-controlled trial was to study the effect of gabapentin on the

The effectiveness of progressive muscle

The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trial

✍ Alexander Molassiotis; Hilary P. Yung; Bernard M. Yam; Flora Y. Chan; T. Mok 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 105 KB

Addition of the neurokinin 1 receptor an

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting : Results from a randomized, double-blind, placebo-controlled trial in Latin America

✍ Sergio Poli-Bigelli; Jose Rodrigues-Pereira; Alexandra D. Carides; Guoguang Juli 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients

✍ Fabrizio Stocchi; Rupam Borgohain; Marco Onofrj; Anthony H.V. Schapira; Mohit Bh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 2 views

## Abstract Safinamide is an α‐aminoamide with both dopaminergic and nondopaminergic mechanisms of action evaluated as an add‐on to dopamine agonist (DA) therapy in early‐stage PD. In this 24‐week, double‐blind study, patients with early PD receiving a stable dose of a single DA were randomized to

Efficacy of lamotrigine in the managemen

Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy : A phase 3 randomized, double-blind, placebo-controlled trial, N01C3

✍ Ravi D. Rao; Patrick J. Flynn; Jeff A. Sloan; Gilbert Y. Wong; Paul Novotny; Dav 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

## Abstract ## BACKGROUND. Lamotrigine, an antiepileptic agent, has been reported as being effective in reducing symptoms of neuropathy associated with various etiologies. Based on such data, a multicenter double‐blind, placebo‐controlled, randomized trial was conducted to evaluate the effect of l

Efficacy of nefazodone in the treatment

Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial

✍ Dora Wynchank; Michael Berk 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

## Abstract Many atypical antipsychotics show antagonism at both serotonergic and dopaminergic neurones and show fewer extrapyramidal side effects (EPS). Nefazodone blocks postsynaptic 5HT~2A~ receptors and weakly inhibits serotonin reuptake. This study aimed to elucidate the role of nefazodone in